Novus Biologicals products are now on bio-techne.com

Antibody News

Caspase Antibody Study Shows Link to Heart Disease

Monday, February 28, 2011 - 08:06

Caspase 3 is a member of the cysteine-aspartic acid protease family and an important mediator of apoptosis. Caspase 3 antibody reagents have been used in cancer, Alzheimer's disease and stem cell research. A recent caspase 3 antibody ELISA study showed elevated levels of the p17 caspase 3 fragment were associated with myocardial infarction in humans. We at Novus Biologicals are one of the leading antibody suppliers of caspase products.

Caspase 3 is one of the effector group of caspases, initiating DNA fragmentation and chromatin condensation in apoptosis, via substrate cleavage following activation by either death ligand or mitochondrial action. It interacts with the initiators, Caspase 8 and...

ABCA1 Mutations: A Risk Factor in Atherosclerosis Related Strokes

Monday, February 21, 2011 - 08:03

The ATP Binding Cassette Transporter (ABCA1) gene encodes the cholesterol regulatory efflux protein, which plays a key role in lipid metabolism. ABCA1 antibody products are an important part of any antibody catalog covering atherosclerosis disease research.

Atherosclerosis (narrowing of the arteries) is characterized by a build-up of fatty plaques, containing cholesterol, causing arteries to narrow. These plaques can then become ulcerated, causing blood clots to form. If this occurs in the carotid arteries the clots can travel to the brain, causing a stroke. In the general population, low plasma HDLC levels are well documented to increase the risk of coronary heart disease.

ABCA1 antibody studies in animal models have shown ABCA1 gene mutations increase the risk of atherosclerosis. Researchers also discovered that...

TNF Alpha Antibodies as Therapeutic Tools

Monday, February 14, 2011 - 08:00

Tumor Necrosis Factor alpha (TNFa) is a cytokine protein that plays an essential role in inducing the systemic inflammatory response, being expressed in tissues throughout the body. In autoimmune diseases such as rheumatoid arthritis and psoriasis, TNF alpha causes negative clinical effects. These can be controlled by inhibitory TNF antibody drugs, a number of which are now on the market. We at Novus Biologicals have an extensive range of TNF alpha antibodies.

TNF alpha is expressed by a number of cell types, primarily macrophages. TNF antibody research has shown the protein to have a number of effects, both positive and negative. In mice, it causes tumor necrosis when injected into tumor sites, and studies have shown it can inhibit tumor growth, induce apoptosis, and inhibit...

Rad51 Antibody Reveals a Canine Model for Human Breast Cancer

Friday, February 11, 2011 - 07:56

Our antibody catalog includes an extensive range of Rad51 antibody reagents. Encoded by the RAD51 gene, the Rad51 protein plays a vital role in DNA repair, interacting with several other proteins, including BRCA1 and BRCA2, to effect homologous recombination at double-strand breaks. In 2010, German Rad51 antibody studies showed Rad51 levels were significantly raised in canine metastatic tumors. In general there was significant correlation between canine and human oncogenes, suggesting a possible animal model for human breast cancer.

Double-strand breaks (DSBs) are extremely common, and are caused by a number of environmental factors including ionizing radiation,...

Using the Hif-1 Alpha Antibody in Prostate Cancer Research

Monday, February 7, 2011 - 07:51

The Hypoxia-inducible Factor 1 (HIF1) protein is a heterodimeric transcription factor which plays an important role in mammalian oxygen homeostasis in conditions of hypoxia, or low oxygen concentration. HIF-1 alpha antibody reagents are widely used in disease research, as hypoxia is known to contribute to many diseases including cancer, pulmonary hypertension and congenital heart disease. We at Novus Biologicals are one of the leading antibody suppliers of HIF-1 products.

HIF-1 alpha is one of two subunits forming the HIF-1 heterodimer. Under normal conditions it undergoes continual translation, ubiquitination and degradation, but in hypoxic conditions degradation ceases while transcription increases. Expression of HIF-1 alpha is regulated by several enzymes, including the E3 ubiquitin-protein ligase Siah2.

...

HIF-1 Beta Antibody Studies and Developments in Hypoxia Research

Monday, January 31, 2011 - 08:18

We at Novus Biologicals have a large HIF-1 (Hypoxia Inducible Factor-1) antibody catalog, with twenty HIF-1 beta antibody products specifically targeted to the beta subunit of HIF-1, a heterodimer which is known to contribute to many human diseases arising from changes in oxygen homeostasis.

HIF-1 is a transcription factor and key mediator of homeostasis triggered by hypoxia. It drives the transcription of more than 60 genes concerned with anaerobic metabolism, cell survival, cytokine production, the immune reaction, vascularisation and all areas of tissue homeostasis. It is also a key hypoxic regulator of embryonic vascular development.

...

Nestin Antibody Products in Neuronal Cancer Research

Monday, January 24, 2011 - 08:00

Nestin is a large class Vl intermediate filament protein predominantly expressed in the neuroepithelial stem cells of the embryonic central nervous system, although recent nestin antibody studies have shown it expressed in other cell types, including vascular endothelial cells. The first monoclonal nestin antibody was developed by Hockfield and McKay in 1985.

Nestin is widely used as a marker for stem, progenitor, glioma and tumor endothelial cells, and has proven to be a valuable angiogenic marker in tumor studies. It is widely expressed in glioblasta multiformes and primary and metastatic melanomas, though not metastatic carcinomas.

...

The NOTCH Antibody Family

Monday, January 17, 2011 - 07:53

The notch proteins are single-pass membrane receptors controlling a highly conserved signalling pathway. In vertebrates, the notch family comprises four transmembrane receptors encoded by four individual genes (NOTCH1 - 4). We at Novus Biologicals are leading NOTCH antibody suppliers, with an extensive range of NOTCH antibody products.

In 1999, the notch signalling cascade was shown to play multiple roles in cell fate decisions, controlling the cellular response to intrinsic or extrinsic signals associated with developmental programming. Notch signalling is an important initiator of cellular differentiation and proliferation, as well as apoptosis, and a basic developmental tool for morphogenesis and organ formation.

...

Epitope Tags and the V5 Tag Antibody

Wednesday, January 12, 2011 - 07:17

We at Novus Biologicals have a large antibody catalog targeted to epitope tags. They include C-Myc, GFP, HA, DYKDDDDK, and V5 Tag antibody reagents. The V5 tag antibody recognizes the artificially engineered V5 epitope, which is formed of amino acid residues 95-108 of the simian virus 5 RNA polymerase alpha subunit.

Epitope tagging is widely used in proteomics and genetic studies. The epitope is, of course, the portion of the antigen protein to which the antibody binds. An epitope tag is an artificial epitope that is recognized by a common antibody. The genetic sequence of the tag is engineered using recombinant DNA techniques, and grafted into the protein of interest by placing the encoded sequence of the epitope into a matching open reading frame. The antibody raised...

EEA1 Antibodies in Endosomal Transport and Signalling Studies

Monday, January 10, 2011 - 07:05

EEA1, or Early Endosome Antigen 1, is a phospholipid-binding protein essential for endosomal membrane trafficking and fusion, and is a useful endosomal marker. We at Novus Biologicals have an extensive EEA1 antibody catalog, with antibodies that have been cited in many publications.

In 2005, R. Bhattacharya, et al. used antibodies from our EEA1 catalog to investigate the role of dynamin-2 in regulating VEGFR2-mediated endothelial signalling. VEGFR-2, or Vascular Endothelial Growth Factor Receptor-2 (also called KDR) is a receptor tyrosine kinase enzyme which regulates a number of signalling pathways in vascular endothelial cells, in response to its ligand Vascular Permeability Factor (VPF)/VEGF. Regulation includes chemotactic, mitogenic, permeability and survival signals. However, the...

Pages


Blog Topics


Archives